A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA
Hypoxia (little of no oxygen) is considered to be an important characteristic of a patient's
tumour that may help predict patient outcomes and/or help inform patient management
decisions. 18F-FAZA Positron Emission Tomography (PET) can detect hypoxic tumours because
18F-FAZA accumulates in hypoxic tissues. This study is being done to learn more about the
processes by which 18F-FAZA is absorbed, distributed, metabolized (built-up and broken down)
and eliminated by the body.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society